FDA approved Clinical trials for Type-2 Diabetes Using Stem cell Science| Dr. Anand Srivastava| GIOSTAR

March 28, 2023

Dr. Anand Srivastava, Chairman, and Co-founder of Global Institute of Stem Cell Therapy and Research (GIOSTAR) is explaining sharing great news that US FDA has given Pre-IND approval to carry out a Clinical trial to treat Type-2 diabetes patients using Stem cell Science. 

Posted in

Recent Blog

GIOSTAR: The Shining Star of Modern Healthcare Industry & BioTech
March 28, 2023
Giostar has agreed to commercialize and promote dcgi (Indian FDA) approved stem cell therapies for critical lab ischemia and osteoarthritis
March 28, 2023
Dr. Anand Srivastava, GIOSTAR Co-Founder: How Does Cell Therapy Work?
March 28, 2023

Latest News

Honourable Speaker DR Anand Srivastava at 1ST INTERNATIONAL CONFERENCE ON MEDICINE AND RESEARCH (ICMR-21)
March 28, 2023
Health Talk on Metabolic Diseases Can Be Cured by Stem Cell Therapy at USTM, Guwahati on Dec 18, 2021, by DR. Anand Srivastava Chairman GIOSTAR- USA.
March 28, 2023
SAASCR honours GIOSTAR chairman DR. Anand & 9 Indian American Scientists for their Outstanding Cancer Researching
March 28, 2023

Videos

Meet Dr. Anand Srivastava
March 29, 2023
Dr Anand Srivastava of GIOSTAR Discusses How Stem Cells and Regenerative Therapy Treat Diabetes
March 29, 2023
What is Stem Cell Therapy? by Dr. Anand Srivastava | 40th Vikram Sarabhai Memorial Lecture | GIOSTAR
March 29, 2023